{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:17:38Z","timestamp":1719015458299},"reference-count":5,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.<\/jats:p>","DOI":"10.61409\/v01240012","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T08:35:03Z","timestamp":1718008503000},"page":"1-4","source":"Crossref","is-referenced-by-count":0,"title":["Life-threatening vaginal bleeding after starting rivaroxaban treatment"],"prefix":"10.61409","author":[{"given":"Luna Fabricius","family":"Ekenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line Markdanner","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Pehrson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Speed V, Patel JP, Arya R. Bleeding issues in women prescribed anticoagulation. Thromb Update. 2021;5:100068. https:\/\/doi.org\/10.1016\/j.tru.2021.100068","DOI":"10.1016\/j.tru.2021.100068"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Beyer-Westendorf J, Michalski F, Tittl L et al. Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series. Lancet Haematol. 2016;3(10):e480-e488. https:\/\/doi.org\/10.1016\/S2352-3026(16)30111-9","DOI":"10.1016\/S2352-3026(16)30111-9"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Eworuke E, Hou L, Zhang R et al. Risk of severe abnormal uterine bleeding associated with rivaroxaban compared with apixaban, dabigatran and warfarin. Drug Saf. 2021;44(7):753-763. https:\/\/doi.org\/10.1007\/s40264-021-01072-0","DOI":"10.1007\/s40264-021-01072-0"},{"key":"ref3","unstructured":"Hellfritzsch M, Hvas AM, Dueholm M et al. Menoragi under antikoagulansbehandling. Ugeskr L\u00e6ger. 2020;182:V08200614."},{"key":"ref4","unstructured":"Dansk Cardiologisk Selskab. 14. Antikoagulationsbehandling. Dansk Cardiologisk Selskab, 2023. https:\/\/nbv.cardio.dk\/ak (4. feb 2024)"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:39:59Z","timestamp":1718969999000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V01240012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":5,"URL":"https:\/\/doi.org\/10.61409\/v01240012","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}